| The implementation of managed entry agreements in Central and Eastern Europe: findings and implications A Ferrario, D Arāja, T Bochenek, T Čatić, D Dankó, M Dimitrova, J Fürst, ... Pharmacoeconomics 35, 1271-1285, 2017 | 162 | 2017 |
| The development of a consistent Europe-wide approach to investigating the economic impact of myalgic encephalomyelitis (ME/CFS): A report from the European Network on ME/CFS … DFH Pheby, D Araja, U Berkis, E Brenna, J Cullinan, JD de Korwin, L Gitto, ... Healthcare 8 (2), 88, 2020 | 49 | 2020 |
| A literature review of GP knowledge and understanding of ME/CFS: A report from the socioeconomic working group of the European Network on ME/CFS (EUROMENE) DFH Pheby, D Araja, U Berkis, E Brenna, J Cullinan, JD de Korwin, L Gitto, ... Medicina 57 (1), 7, 2020 | 36 | 2020 |
| Shadow burden of undiagnosed myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) on society: Retrospective and Prospective—In Light of COVID-19 D Araja, U Berkis, A Lunga, M Murovska Journal of clinical medicine 10 (14), 3017, 2021 | 35 | 2021 |
| Perceptions of European ME/CFS experts concerning knowledge and understanding of ME/CFS among primary care physicians in Europe: a report from the European ME/CFS research … J Cullinan, DFH Pheby, D Araja, U Berkis, E Brenna, JD de Korwin, L Gitto, ... Medicina 57 (3), 208, 2021 | 16 | 2021 |
| COVID-19 pandemic-revealed consistencies and inconsistencies in healthcare: a medical and organizational view D Araja, U Berkis, M Murovska Healthcare 10 (6), 1018, 2022 | 14 | 2022 |
| Comparative survey of people with ME/CFS in Italy, Latvia, and the UK: a report on behalf of the socioeconomics Working group of the European ME/CFS research network (EUROMENE) E Brenna, D Araja, DFH Pheby Medicina 57 (3), 300, 2021 | 11 | 2021 |
| The role of prevention in reducing the economic impact of me/Cfs in Europe: A report from the socioeconomics working Group of the European Network on me/Cfs (Euromene) DFH Pheby, D Araja, U Berkis, E Brenna, J Cullinan, JD de Korwin, L Gitto, ... Medicina 57 (4), 388, 2021 | 5 | 2021 |
| Resilience and complex adaptive systems: a perspective on healthcare D Araja Journal of Business Management 20, 2022 | 3 | 2022 |
| Vaccine Vigilance System: Considerations on the Effectiveness of Vigilance Data Use in COVID-19 Vaccination D Araja, A Krumina, Z Nora-Krukle, U Berkis, M Murovska Vaccines 10 (12), 2115, 2022 | 3 | 2022 |
| Pharmaceutical enterprises’ market entry strategies D Araja, E Sumilo University of Latvia, 2020 | 3 | 2020 |
| Multi-criteria decision analysis as a tool for evaluation of unmet needs in health care D Araja SHS Web of Conferences 51, 02001, 2018 | 3 | 2018 |
| The advantages of an integrative approach in the primary healthcare of Post-COVID-19 and ME/CFS patients D Araja, A Krumina, U Berkis, Z Nora-Krukle, M Murovska COVID-19 Pandemic, Mental Health and Neuroscience-New Scenarios for …, 2022 | 2 | 2022 |
| PMU29 Burden of COVID-19 Consequences: an Example of Post-viral Chronic Fatigue Syndrome D Araja, U Berkis, A Lunga, M Murovska Value in Health 24, S149-S150, 2021 | 2 | 2021 |
| Mapping of The Biosimilar Drug Policy in 10 Central Eastern European Countries A Inotai, M Csanadi, G Petrova, T Bochenek, T Tesar, K York, L Fuksa, ... Value in Health 19 (7), A504-A505, 2016 | 2 | 2016 |
| Managed entry agreements for new medicines in the Baltic countries D Arāja, K Kõlves EuroHealth 22 (1), 27-30, 2016 | 2 | 2016 |
| Economic evaluation as a decision-making tool in health care D Araja SHS Web of Conferences 2, 00002, 2012 | 2 | 2012 |
| OPPORTUNITIES FOR ASSESSMENT OF HEALTH CARE SYSTEM'S EFFICIENCY: THREE-LEVELS EVALUATION MODEL. D ARĀJA, J PRIEDE Journal of Economics & Management Research, 2018 | 1 | 2018 |
| RESOURCES OF HEALTH CARE FINANCING IN LATVIA: HISTORICAL REVIEW AND EVENTUAL CHANGES. D ARĀJA, K KRŪZS Journal of Economics & Management Research, 2016 | 1 | 2016 |
| Health System Research Opportunities for Assessment of The National Health Care System D Araja Value in Health 18 (7), A574-A575, 2015 | 1 | 2015 |
